SALZER, Ulrich, Andrea MAUL-PAVICIC, Charlotte CUNNINGHMA-RUNDLES, Simon URSCHEL, Berd BELOHRADSKY, Jiří LITZMAN, Are HOLM, José Luis FRANCO, Alessandro PLEBANI, Lennart HAMMARSTROM, Andrea SKRABL, Wolfgang SCHWINGER and Bodo GRIMBACHER. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol. 2004, vol. 113, No 3, p. 234-240, 8 pp. ISSN 1521-6616.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name ICOS deficiency in patients with common variable immunodeficiency
Name in Czech Deficit ICOS u pacientů s běžným variabilním imunodeficitem
Authors SALZER, Ulrich (276 Germany), Andrea MAUL-PAVICIC (276 Germany), Charlotte CUNNINGHMA-RUNDLES (840 United States of America), Simon URSCHEL (276 Germany), Berd BELOHRADSKY (276 Germany), Jiří LITZMAN (203 Czech Republic, guarantor), Are HOLM (276 Germany), José Luis FRANCO (170 Colombia), Alessandro PLEBANI (380 Italy), Lennart HAMMARSTROM (752 Sweden), Andrea SKRABL (40 Austria), Wolfgang SCHWINGER (276 Germany) and Bodo GRIMBACHER (276 Germany).
Edition Clin Immunol, 2004, 1521-6616.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher Sweden
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.034
RIV identification code RIV/00216224:14110/04:00030933
Organization unit Faculty of Medicine
UT WoS 000224975700004
Keywords in English CVID; ICOS; Immunodeficiency
Tags CVID, ICOS, immunodeficiency
Changed by Changed by: prof. MUDr. Jiří Litzman, CSc., učo 403. Changed: 2/4/2010 08:13.
Abstract
Common variable immunodeficiency (CVID) is the most frequent clinically significant primary antibody deficiency in man, predisposing to recurrent bacterial infections. Recently, we showed that the homozygous loss of the inducible costimulator (ICOS) on activated T cells may result in an adult onset form of CVID with autosomal recessive inheritance (AR-CVID). We screened 181 sporadic CVID patients and 13 CVID patients from nine families with AR-CVID for mutations in ICOS by genomic DNA sequencing. In the AR-CVID families, the genomic integrity of the ligand for ICOS (ICOS-L) was also evaluated. In two of the nine AR-CVID families, we identified five individuals with ICOS deficiency, carrying the identical large genomic deletion of ICOS as previously described. In the remaining seven AR-CVID families, we subsequently sequenced the coding region of the ICOS ligand but found no mutations. The incidence of ICOS deficiency among patients with CVID is less than 5%. Worldwide, there are now a total of nine patients diagnosed with ICOS deficiency most likely due to a common founder. ICOS-L deficiency could not be identified in families with AR-CVID
Abstract (in Czech)
Výskyt mutace genu ICOS u pacientů s běžným variabilním imunodeficitem.
PrintDisplayed: 27/4/2024 07:33